Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia

In order to elucidate mechanisms for severe acute respiratory syndrome coronavirus 2 vaccination success in hematological neoplasia, we, herein, provide a comprehensive characterization of the spike-specific T-cell and serological immunity induced in 130 patients in comparison with 91 healthy contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelmann, Robby, Jaekel, Nadja, Jotschke, Sabrina, Ludwig-Kraus, Beatrice, Kraus, Frank Bernhard, Kumari, Neha, Schulze, Susann, Hecker, Michael, Zahn, Christina, Al-Ali, Haifa Kathrin, Junghanss, Christian, Böttcher, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065874/
https://www.ncbi.nlm.nih.gov/pubmed/36947191
http://dx.doi.org/10.1182/bloodadvances.2022009054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065874/
https://www.ncbi.nlm.nih.gov/pubmed/36947191
http://dx.doi.org/10.1182/bloodadvances.2022009054

Ejemplares similares